These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Delaware
|
61-1547850
|
|
|
(State or other jurisdiction of
|
(I.R.S. Employer
|
|
|
incorporation or organization)
|
Identification No.)
|
|
Large Accelerated Filer
¨
|
Accelerated Filer
¨
|
|
Non-accelerated Filer
¨
|
Smaller Reporting Company
x
|
|
(Do not check if a smaller reporting company.)
|
|
|
(i)
|
filing Exchange Act reports, and
|
|
|
(ii)
|
investigating, analyzing and consummating an acquisition.
|
|
Fiscal Year
Ended
December 31,
2010
|
Fiscal Year
Ended
December 31,
2009
|
For the
Cumulative
Period from
November 16,
2007 (Inception)
to
December 31,
2010
|
||||||||||
|
Net Cash (Used in) Operating Activities
|
$ |
(19,244
|
) | $ | (21,366 | ) | $ |
(83,102
|
) | |||
|
Net Cash (Used in) Investing Activities
|
- | - | - | |||||||||
|
Net Cash Provided by Financing Activities
|
$ | 35,000 | $ | 25,000 | $ | 110,000 | ||||||
|
Net Increase in Cash and Cash Equivalents
|
$ |
15,756
|
$ | 3,634 | $ |
26,898
|
||||||
|
Page(s)
|
||
|
Report of Independent Registered Public Accounting firm
|
F - 2
|
|
|
Financial Statements:
|
||
|
Balance Sheets as of December 31, 2010 and 2009
|
F - 3
|
|
|
Statements of Operations for the Years Ended December 31, 2010 and 2009 and for the Cumulative Period from Inception (November 16, 2007) through December 31, 2010
|
F - 4
|
|
|
Statements of Stockholder’s Equity (Deficit) for the Cumulative Period from Inception (November 16, 2007) through December 31, 2010
|
F - 5
|
|
|
Statements of Cash Flows for the Years Ended December 31, 2010 and 2009 and for the Cumulative Period from Inception (November 16, 2007) through December 31, 2010
|
F - 6
|
|
|
Notes to Financial Statements
|
F - 7 to F - 9
|
|
December 31,
|
December 31,
|
|||||||
|
2010
|
2009
|
|||||||
|
Assets
|
||||||||
|
Current assets:
|
||||||||
|
Cash and cash equivalents
|
$ | 26,898 | $ | 11,142 | ||||
|
Prepaid expenses
|
2,500 | 1,875 | ||||||
|
Total assets
|
$ | 29,398 | $ | 13,017 | ||||
|
Liabilities and stockholders' equity (deficit)
|
||||||||
|
Current liabilities:
|
||||||||
|
Accounts payable and accrued expenses
|
$ | 10,389 | $ | 6,613 | ||||
|
Notes payable, stockholders
|
60,000 | 25,000 | ||||||
|
Total liabilities
|
70,389 | 31,613 | ||||||
|
Stockholders' equity (deficit)
|
||||||||
|
Preferred stock, $0.0001 par value; 10,000,000 shares authorized; no shares issued and outstanding
|
- | - | ||||||
|
Common stock, $0.0001 par value; 100,000,000 shares authorized; 5,000,000 shares issued and outstanding
|
500 | 500 | ||||||
|
Additional paid-in capital
|
49,500 | 49,500 | ||||||
|
Deficit accumulated during the development stage
|
(90,991 | ) | (68,596 | ) | ||||
|
Total stockholders' equity (deficit)
|
(40,991 | ) | (18,596 | ) | ||||
|
Total liabilities and stockholders' equity (deficit)
|
$ | 29,398 | $ | 13,017 | ||||
|
Cumulative
|
||||||||||||
|
Period From
|
||||||||||||
|
Year Ended
|
Year Ended
|
November 16, 2007
|
||||||||||
|
December 31,
|
December 31,
|
(Inception) Through
|
||||||||||
|
2010
|
2009
|
December 31, 2010
|
||||||||||
|
Operating expenses:
|
||||||||||||
|
Formation costs
|
$ | - | $ | - | $ | 15,643 | ||||||
|
General and administrative
|
20,509 | 19,158 | 72,624 | |||||||||
|
Operating loss
|
(20,509 | ) | (19,158 | ) | (88,267 | ) | ||||||
|
Interest expense
|
1,886 | 838 | 2,724 | |||||||||
|
Net loss
|
$ | (22,395 | ) | $ | (19,996 | ) | $ | (90,991 | ) | |||
|
Net loss per basic and diluted common share
|
$ | (0.00 | ) | $ | (0.00 | ) | $ | (0.02 | ) | |||
|
Weighted-average number of common shares outstanding
|
5,000,000 | 5,000,000 | 4,877,301 | |||||||||
|
.
|
Deficit
|
|||||||||||||||||||
|
Accumulated
|
Total
|
|||||||||||||||||||
|
Additional
|
During the
|
Stockholders'
|
||||||||||||||||||
|
Common Stock
|
Paid-In
|
Development
|
Equity
|
|||||||||||||||||
|
Shares
|
Amount
|
Capital
|
Stage
|
(Deficit)
|
||||||||||||||||
|
Issuance of common stock on
December 14, 2007 at $0.01 per share
|
5,000,000 | $ | 500 | $ | 49,500 | $ | - | $ | 50,000 | |||||||||||
|
Net loss
|
- | - | - | (14,977 | ) | (14,977 | ) | |||||||||||||
|
Balance at December 31, 2007
|
5,000,000 | 500 | 49,500 | (14,977 | ) | 35,023 | ||||||||||||||
|
Net loss
|
- | - | - | (33,623 | ) | (33,623 | ) | |||||||||||||
|
Balance at December 31, 2008
|
5,000,000 | 500 | 49,500 | (48,600 | ) | 1,400 | ||||||||||||||
|
Net loss
|
- | - | - | (19,996 | ) | (19,996 | ) | |||||||||||||
|
Balance at December 31, 2009
|
5,000,000 | 500 | 49,500 | (68,596 | ) | (18,596 | ) | |||||||||||||
|
Net loss
|
- | - | - | (22,395 | ) | (22,395 | ) | |||||||||||||
|
Balance at December 31, 2010
|
5,000,000 | $ | 500 | $ | 49,500 | $ | (90,991 | ) | $ | (40,991 | ) | |||||||||
|
Cumulative
|
||||||||||||
|
Period From
|
||||||||||||
|
Year ended
|
Year ended
|
November 16, 2007
|
||||||||||
|
December 31,
|
December 31,
|
(Inception) Through
|
||||||||||
|
2010
|
2009
|
December 31, 2010
|
||||||||||
|
Operating activities
|
||||||||||||
|
Net loss
|
$ | (22,395 | ) | $ | (19,996 | ) | $ | (90,991 | ) | |||
|
Adjustments to reconcile net loss to net cash used in operating activities:
|
||||||||||||
|
Increase in prepaid expenses
|
(625 | ) | (1,875 | ) | (2,500 | ) | ||||||
|
Increase in accounts payable and accrued expenses
|
3,776 | 505 | 10,389 | |||||||||
|
Net cash used in operating activities
|
(19,244 | ) | (21,366 | ) | (83,102 | ) | ||||||
|
Financing activities
|
||||||||||||
|
Proceeds from notes payable, stockholders
|
35,000 | 25,000 | 70,000 | |||||||||
|
Payments on notes payable, stockholders
|
- | - | (10,000 | ) | ||||||||
|
Proceeds from issuance of common stock
|
- | - | 50,000 | |||||||||
|
Net cash provided by financing activities
|
35,000 | 25,000 | 110,000 | |||||||||
|
Net increase in cash and cash equivalents
|
15,756 | 3,634 | 26,898 | |||||||||
|
Cash and cash equivalents at beginning of period
|
11,142 | 7,508 | - | |||||||||
|
Cash and cash equivalents at end of period
|
$ | 26,898 | $ | 11,142 | $ | 26,898 | ||||||
|
1.
|
Nature of Operations and Significant Accounting Policies
|
|
1.
|
Nature of Operations and Significant Accounting Policies (continued)
|
|
2.
|
Notes Payable, Stockholders
|
|
3.
|
Preferred Stock
|
|
4.
|
Common Stock
|
|
5.
|
Income Taxes
|
|
December 31,
|
December 31,
|
|||||||
|
2010
|
2009
|
|||||||
|
Deferred tax asset:
|
||||||||
|
Capitalized formation costs
|
$ |
13,200
|
$ | 10,200 | ||||
|
Net operating loss carryforward
|
400 | 100 | ||||||
|
Valuation allowance
|
(13,600
|
) | (10,300 | ) | ||||
|
Net deferred tax asset recognized
|
$ | — | $ | — | ||||
|
Year Ended
|
Year Ended
|
|||||||
|
December 31,
|
December 31,
|
|||||||
|
2010
|
2009
|
|||||||
|
US federal income tax benefit at statutory rate
|
$ |
(3,300
|
) | $ | (3,000 | ) | ||
|
Change in valuation allowance
|
3,300
|
3,000 | ||||||
|
Benefit from income taxes
|
$ | — | $ | — | ||||
|
6.
|
Commitment
|
|
|
·
|
Pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the Company;
|
|
|
·
|
Provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that our receipts and expenditures are being made only in accordance with authorizations of the Company’s management and directors; and
|
|
|
·
|
Provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on financial statements.
|
|
Name
|
Age
|
Position
|
||
|
John Pappajohn
|
82
|
President and Director
|
||
|
Matthew P. Kinley
|
|
43
|
|
Secretary, Chief Financial Officer and Director
|
|
Name
|
Filing Date
Registration
Statement
|
Operating
Status
|
SEC File
Number
|
Pending Business
Combinations
|
Additional
Information
|
|||||
|
Healthcare Acquisition Corp.
|
April 25, 2005
|
Effective July 28, 2005
|
001-32587
|
Completed August 3, 2007
|
Mr. Pappajohn has served as Chairman of the company since inception. Mr. Pappajohn also served as Secretary of the company until he resigned on August 3, 2007. Mr. Kinley served as President, Treasurer and director of the company until he resigned on August 3, 2007.
|
|||||
|
Zeta Acquisition Corp. I, Inc. and Zeta Acquisition Corp. III Inc.
|
January 31, 2008
|
Effective April 1, 2008
|
000-53056
000-53058
|
None.
|
Messrs. Pappajohn and Kinley have been officers and directors of these companies since inception.
|
|
Option
|
All Other
|
|||||||||||
|
Name and Position
|
Year
|
Salary
|
Bonus
|
Awards
|
Compensation
|
Total
|
||||||
|
John Papajohn,
|
2010
|
None
|
None
|
None
|
None
|
None
|
||||||
|
President and Director
|
2009
|
None
|
None
|
None
|
None
|
None
|
||||||
|
Matthew P. Kinley,
|
2010
|
None
|
None
|
None
|
None
|
None
|
||||||
|
Chief Financial Officer,
|
2009
|
None
|
None
|
None
|
None
|
None
|
||||||
|
Secretary and Director
|
|
|
|
|
|
|
|
Name and Address
|
Amount and Nature of
Beneficial Ownership
|
Percentage
of Class
|
||||||
|
John Pappajohn (1)
c/o Equity Dynamics Inc.
666 Walnut Street, Suite 2116
Des Moines, Iowa 50309
|
2,000,000 | 40 | % | |||||
|
Matthew P. Kinley (2)
c/o Equity Dynamics Inc.
666 Walnut Street, Suite 2116
Des Moines, Iowa 50309
|
2,000,000 | 40 | % | |||||
|
AANA Ltd.
c/o Argyris Vassiliou
94 Nathan Hale Drive
Stamford, Connecticut 06902
|
625,000 | (3) | 12.5 | % | ||||
|
NICALE Partners
c/o Argyris Vassiliou
94 Nathan Hale Drive
Stamford, Connecticut 06902
|
375,000 | (4) | 7.5 | % | ||||
|
|
(1)
|
Mr. Pappajohn serves as President and director of the Company.
|
|
(2)
|
Mr. Kinley serves as Secretary, Chief Financial Officer and director of the Company.
|
|
|
(3)
|
Represents share of common stock owned by AANA Ltd. Mr. Vassiliou, his wife and his two minor children are the owner of AANA Ltd. Mr. Vassiliou has sole investment and voting power of these shares. Therefore, Mr. Vassiliou may be deemed the beneficial owner of the shares of common stock held by AANA Ltd.
|
|
|
(4)
|
Represents share of common stock owned by NICALE Partners. Mr. Vassiliou’s minor children are the owners of NICALE Partners. Mr. Vassiliou has sole investment and voting power of these shares. Therefore, Mr. Vassiliou may be deemed the beneficial owner of the shares of common stock held by NICALE Partners.
|
|
Statement
|
Page*
|
|
|
Index to Financial Statements
|
F-1
|
|
|
Report of Independent Registered Public Accounting Firm
|
F-2
|
|
|
Balance Sheets
|
F-3
|
|
|
Statements of Operations
|
F-4
|
|
|
Statement of Changes in Stockholder’s Equity (Deficit)
|
F-5
|
|
|
Statements of Cash Flows
|
F-6
|
|
|
Notes to Financial Statements
|
F-7
|
|
Exhibit
|
Description
|
|
|
*3.1
|
Certificate of Incorporation
|
|
|
*3.2
|
By-laws
|
|
|
31.1
|
Certification of the Company’s Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, with respect to the registrant’s Annual Report on Form 10-K for the year ended December 31, 2010
|
|
|
31.2
|
Certification of the Company’s Principal Executive Officer and Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, with respect to the registrant’s Annual Report on Form 10-K for the year ended December 31, 2010
|
|
|
32.1
|
Certification of the Company’s Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes Oxley Act of 2002
|
|
|
32.2
|
Certification of the Company’s Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes Oxley Act of 2002
|
|
*
|
Filed as an exhibit to the Company's registration statement on Form 10, as filed with the SEC on February 1, 2008, and incorporated herein by this reference.
|
|
ZETA ACQUISITION CORP. II
|
||
|
Dated: March 31, 2011
|
By:
|
/s/ John Pappajohn
|
|
John Pappajohn
|
||
|
President and Director
|
||
|
Principal Executive Officer
|
||
|
Dated: March 31, 2011
|
By:
|
/s/ Matthew P. Kinley
|
|
Matthew P. Kinley
|
||
|
Secretary, Chief Financial Officer
|
||
|
Principal Accounting Officer
|
||
|
Principal Financial Officer
|
||
|
Title
|
Date
|
|||
|
/s/ John Pappajohn
|
President and Director
|
March 31, 2011
|
||
|
John Pappajohn
|
||||
|
/s/ Matthew P. Kinley
|
Secretary, Chief Financial
|
March 31, 2011
|
||
|
Matthew P. Kinley
|
|
Officer and Director
|
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|